Articles tagged with “ai-in-pharmacovigilance”

An analysis of EMA and HMA's 2025 AI Observatory report, covering Scientific Explorer's March 2026 expansion, the NDSG 2026-2028 workplan, EU AI Act timelines, and pharmacovigilance AI governance as of 2026.

Guide to deploying AI in pharmacovigilance under the CIOMS XIV framework. Review core principles for risk-based oversight, model validation, and governance.

Analyze TransCelerate guidelines for implementing AI in pharmacovigilance. Review a comprehensive roadmap for compliance with FDA and EMA safety regulations.

Learn how to quantify AI ROI in pharmacovigilance. This guide analyzes cost drivers, payback periods, and metrics for automating PV case processing workflows.

Updated 2026 guide to pharmacovigilance technology covering GenAI/LLMs in PV, AI-powered case processing, signal detection, FDA-EMA AI guidance, and data standards for drug safety